Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

CONy 2022 | Are outcomes of RCTs relevant to treat epilepsy patients or are real-world trials more valuable?

Martin Brodie • 23 Mar 2022
CONy 2022
Epilepsy

Martin Brodie, MD, University of Glasgow, Glasgow, UK, discusses the relevance of outcomes of randomized controlled trials (RCTs) and real-world studies to epilepsy care. Prof. Brodie considers that for the treatment of epilepsy patients, real-world studies based on everyday clinical practice are more valuable than RCTs. However, without the RCTs, there wouldn’t be data available to allow the approval of drugs and consequently their use in clinical practice. This interview was conducted during the 2022 World Congress on Controversies in Neurology (CONy) meeting.

More from Martin Brodie

The genetics of epilepsy & treatment availability
2:22
The genetics of epilepsy & treatment availability
Martin Brodie • 23 Mar 2022
The need for novel treatments that can modify the development & progression of epilepsy
3:13
The need for novel treatments that can modify the development & progression of epilepsy
Martin Brodie • 23 Mar 2022
The relationship between epilepsy and depression
1:56
The relationship between epilepsy and depression
Martin Brodie • 23 Oct 2020
The benefits of drug combination therapy to treat epilepsy
3:38
The benefits of drug combination therapy to treat epilepsy
Martin Brodie • 23 Oct 2020

Related Videos

Which emerging epilepsy therapies are likely to change clinical practice?
9:12
Which emerging epilepsy therapies are likely to change clinical practice?
William Alves Martins • 20 Oct 2026
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
8:05
Phase II/III POWER1: efficacy, safety and lessons learned for vormatrigine in epilepsy
William Alves Martins • 20 Oct 2026
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
9:58
Emerging precision therapies reshaping the antiseizure medication landscape in epilepsy
William Alves Martins • 20 Oct 2026
Emerging gene therapies for Dravet syndrome and other DEEs
10:41
Emerging gene therapies for Dravet syndrome and other DEEs
William Alves Martins • 20 Oct 2026

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals